China · Delayed Price · Currency is CNY Jafron Biomedical Statistics
Total Valuation
SHE:300529 has a market cap or net worth of CNY 16.02 billion. The enterprise value is 14.97 billion.
| Market Cap | 16.02B |
| Enterprise Value | 14.97B |
Important Dates
The next estimated earnings date is Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | May 26, 2025 |
Share Statistics
SHE:300529 has 774.36 million shares outstanding. The number of shares has decreased by -3.68% in one year.
| Current Share Class | 774.36M |
| Shares Outstanding | 774.36M |
| Shares Change (YoY) | -3.68% |
| Shares Change (QoQ) | +2.42% |
| Owned by Insiders (%) | 50.26% |
| Owned by Institutions (%) | 9.95% |
| Float | 379.86M |
Valuation Ratios
The trailing PE ratio is 32.87 and the forward PE ratio is 21.28.
| PE Ratio | 32.87 |
| Forward PE | 21.28 |
| PS Ratio | 7.86 |
| PB Ratio | 4.67 |
| P/TBV Ratio | 4.82 |
| P/FCF Ratio | 27.69 |
| P/OCF Ratio | 21.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.22, with an EV/FCF ratio of 25.86.
| EV / Earnings | 31.06 |
| EV / Sales | 7.34 |
| EV / EBITDA | 20.22 |
| EV / EBIT | 25.30 |
| EV / FCF | 25.86 |
Financial Position
The company has a current ratio of 4.26, with a Debt / Equity ratio of 0.42.
| Current Ratio | 4.26 |
| Quick Ratio | 3.69 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 1.93 |
| Debt / FCF | 2.47 |
| Interest Coverage | 10.56 |
Financial Efficiency
Return on equity (ROE) is 14.20% and return on invested capital (ROIC) is 19.85%.
| Return on Equity (ROE) | 14.20% |
| Return on Assets (ROA) | 6.64% |
| Return on Invested Capital (ROIC) | 19.85% |
| Return on Capital Employed (ROCE) | 12.19% |
| Weighted Average Cost of Capital (WACC) | 6.56% |
| Revenue Per Employee | 728,514 |
| Profits Per Employee | 172,253 |
| Employee Count | 2,797 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.37 |
Taxes
In the past 12 months, SHE:300529 has paid 127.18 million in taxes.
| Income Tax | 127.18M |
| Effective Tax Rate | 21.04% |
Stock Price Statistics
The stock price has decreased by -23.74% in the last 52 weeks. The beta is 0.48, so SHE:300529's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -23.74% |
| 50-Day Moving Average | 20.15 |
| 200-Day Moving Average | 21.88 |
| Relative Strength Index (RSI) | 58.29 |
| Average Volume (20 Days) | 5,534,374 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300529 had revenue of CNY 2.04 billion and earned 481.79 million in profits. Earnings per share was 0.63.
| Revenue | 2.04B |
| Gross Profit | 1.61B |
| Operating Income | 591.55M |
| Pretax Income | 604.40M |
| Net Income | 481.79M |
| EBITDA | 736.68M |
| EBIT | 591.55M |
| Earnings Per Share (EPS) | 0.63 |
Balance Sheet
The company has 2.49 billion in cash and 1.43 billion in debt, with a net cash position of 1.06 billion or 1.36 per share.
| Cash & Cash Equivalents | 2.49B |
| Total Debt | 1.43B |
| Net Cash | 1.06B |
| Net Cash Per Share | 1.36 |
| Equity (Book Value) | 3.43B |
| Book Value Per Share | 4.43 |
| Working Capital | 2.23B |
Cash Flow
In the last 12 months, operating cash flow was 752.62 million and capital expenditures -173.94 million, giving a free cash flow of 578.69 million.
| Operating Cash Flow | 752.62M |
| Capital Expenditures | -173.94M |
| Free Cash Flow | 578.69M |
| FCF Per Share | 0.75 |
Margins
Gross margin is 79.02%, with operating and profit margins of 29.03% and 23.64%.
| Gross Margin | 79.02% |
| Operating Margin | 29.03% |
| Pretax Margin | 29.66% |
| Profit Margin | 23.64% |
| EBITDA Margin | 36.15% |
| EBIT Margin | 29.03% |
| FCF Margin | 28.40% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 3.87%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 3.87% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 134.11% |
| Buyback Yield | 3.68% |
| Shareholder Yield | 7.65% |
| Earnings Yield | 3.01% |
| FCF Yield | 3.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 20, 2020. It was a forward split with a ratio of 1.9.
| Last Split Date | May 20, 2020 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
SHE:300529 has an Altman Z-Score of 7.59 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.59 |
| Piotroski F-Score | 6 |